← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 3, 2017Last known activity
Aug 18, 2025
Timeline
2010s
- Jun 1, 2015
ALX Oncology— Founded
Drugs by trial phase (20 distinct, 12 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT07085091Lead sponsorPhase 1Aug 18, 2025
- NCT07007559Lead sponsorPhase 1/Phase 2Apr 28, 2025
- NCT05524545Lead sponsorPhase 1Oct 31, 2022
- NCT05467670CollaboratorPhase 2Aug 31, 2022
- NCT05167409CollaboratorPhase 2Jul 14, 2022
- NCT05027139CollaboratorPhase 1/Phase 2Sep 15, 2021
- NCT05002127Lead sponsorPhase 2/Phase 3Aug 31, 2021
- NCT04675333Lead sponsorPhase 2May 10, 2021
- NCT04755244Lead sponsorPhase 1/Phase 2May 5, 2021
- NCT04675294Lead sponsorPhase 2Feb 28, 2021
- NCT04417517Lead sponsorPhase 1/Phase 2Sep 30, 2020
- NCT03013218Lead sponsorPhase 1Feb 3, 2017
Details
- Founded
- Burlingame, CA, US Jun 1, 2015
- Last known activity
- Aug 18, 2025
Notes
formerly known as Alexo Therapeutics, Inc.